Based on the analysis of genomic profiles in H295R cells, a recent study suggested that a major determinant driving proliferation and differentiation in malignant ACC is the interaction of NR5A1 and beta-catenin on chromatin to regulate gene expression (17). The gene discussed is NR5A1; the disease is adrenal cortex carcinoma.